Spironolactone in Covid-19 Induced ARDS

Stop Hypernatremia, Use Metolazone, for Aggressive, Controlled, Effective Diuresis

NCT01617798 ·Status: WITHDRAWN ·Phase: NA

Hydrochloorthiazide and Hypernatriaemie

NCT01974739 ·Status: COMPLETED ·Phase: NA

Nebulised Rt-PA for ARDS Due to COVID-19

NCT04356833 ·Status: COMPLETED ·Phase: PHASE2

Nebulized Furosemide, Heparin, Hypertonic Saline in Mechanically Ventilated Acute Respiratory Distress Syndrome Adult Patients

NCT07286409 ·Status: NOT_YET_RECRUITING ·Phase: NA

Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)

NCT05387278 ·Status: SUSPENDED ·Phase: PHASE1

Hypertonic Saline Therapy in Ambulatory Heart Failure Unit.

NCT04533997 ·Status: COMPLETED ·Phase: PHASE3

Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS

NCT04333368 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in Patients With ARDS

NCT05241067 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Almitrine and COVID-19 Related Hypoxemia

NCT04380727 ·Status: COMPLETED

Effects of Induced Moderate Hypothermia on ARDS Patients Under Venovenous ExtraCorporeal Membrane Oxygenation

NCT05306392 ·Status: UNKNOWN ·Phase: NA

Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia

NCT04609865 ·Status: TERMINATED ·Phase: PHASE3

Kinetics of Surfactant Proteins, Phosphatidylcholine and Body Water in Intensive Care Unit (ICU)

NCT03371680 ·Status: COMPLETED ·Phase: NA

Risk Potential for Organ Dysfunction Associated With Sodium Bicarbonate Therapy (SBT) in Critically Ill Patients

NCT04953013 ·Status: COMPLETED

The Hemodynamic Effects of Hypertonic Saline Preload Versus Coload Measured by Non-invasive Cardiometry in Patients Undergoing TURP Surgery

NCT03324477 ·Status: COMPLETED ·Phase: PHASE4

Effect of Nebulized and Intravenous Hypertonic Saline 3% on the Management of Patients With Acute Respiratory Distress Syndrome

NCT06226402 ·Status: RECRUITING ·Phase: NA

Streptokinase Versus Unfractionated Heparin Nebulization in Severe ARDS

NCT03465085 ·Status: COMPLETED ·Phase: PHASE3

Midodrine for the Treatment of Refractory Hypotension

NCT01531959 ·Status: COMPLETED ·Phase: PHASE3

The Influence of Furosemide on Fluid Balance and Intra-abdominal Pressure in Critically Ill Patients

NCT01072071 ·Status: UNKNOWN ·Phase: NA

Treatment of ARDS With Instilled T3

NCT04115514 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Time Course Evolution of Cardiac Output

NCT03694717 ·Status: COMPLETED

Effect of Oral Water on the Quality of Volume Expansion in Resuscitation Patients

NCT03951519 ·Status: COMPLETED ·Phase: NA

Non-invasive Fluid Management

NCT02892799 ·Status: UNKNOWN ·Phase: NA

Hypertonic Saline and Terlipressin for Sepsis-associated Hypotension

NCT01271114 ·Status: TERMINATED ·Phase: PHASE3

The Effect of Fluid Resuscitation With 0.9% Sodium Chloride Versus Balanced Crystalloid Solution on Renal Function of Sepsis Patients

NCT03277677 ·Status: COMPLETED ·Phase: PHASE3

"Effects of Neuromuscular Blocking Agents on End Expiratory Lung Volume During Moderate-severe ARDS"

NCT04996394 ·Status: COMPLETED